======= CYP2W1 =======
== Gene Information ==
* **Official Symbol**: CYP2W1
* **Official Name**: cytochrome P450 family 2 subfamily W member 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54905|54905]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8TAV3|Q8TAV3]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CYP2W1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CYP2W1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/615967|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Seems to have broad catalytic activity towards several chemicals, including polycyclic aromatic hydrocarbon dihydrodiols and aromatic amines (PubMed:16551781, PubMed:24278521). Active also in the metabolism of indoline substrates and is able to activate aflatoxin B1 into cytotoxic products (PubMed:20805301). Furthermore, it seems to be involved in the oxydation of lysophospholipids and fatty acids (PubMed:22591743). {ECO:0000269|PubMed:16551781, ECO:0000269|PubMed:20805301, ECO:0000269|PubMed:22591743, ECO:0000269|PubMed:24278521}.
|p450|
|aflatoxin B1 metabolic process|
|mycotoxin metabolic process|
|aflatoxin metabolic process|
|organic heteropentacyclic compound metabolic process|
|ether metabolic process|
|toxin metabolic process|
|exogenous drug catabolic process|
|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|
|steroid hydroxylase activity|
|secondary metabolic process|
|cellular ketone metabolic process|
|xenobiotic metabolic process|
|iron ion binding|
|heme binding|
|drug catabolic process|
|cellular response to xenobiotic stimulus|
|response to xenobiotic stimulus|
|endoplasmic reticulum lumen|
|drug metabolic process|
|cell surface|
|intracellular membrane-bounded organelle|
|endoplasmic reticulum membrane|
|oxidation-reduction process|
|response to drug|
|organic acid metabolic process|
|small molecule metabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|-1.86|
|[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-1.72|
|[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|1.79|
|[[:results:exp539|42°C R08 exp539]]|1.81|
|[[:results:exp93|DABN racemic mixture R03 exp93]]|2.07|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9810
* **Expression level (log2 read counts)**: 0.06
{{:chemogenomics:nalm6 dist.png?nolink |}}